✦ LIBER ✦

Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs

✍ Scribed by K. M. Rassnick; R. Al-Sarraf; D. B. Bailey; J. D. Chretin; B. Phillips; C. H. Zwhalen

Book ID: 111220155
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 523 KB
Volume: 8
Category: Article
ISSN: 1476-5810
DOI: 10.1111/j.1476-5829.2010.00211.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II, Open-Label Trial of Single-Age

Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma

✍ K.M. Rassnick; A.S. Moore; D.S. Russell; N.C. Northrup; O. Kristal; D.B. Bailey; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Phase II study of single agent capecitab

Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours

✍ Medley, L; Morel, A N; Farrugia, D; Reed, N; Hayward, N; Davies, J M; Kirichek, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB

Phase II study of single-agent bortezomi

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

✍ Stefan Faderl; Kanti Rai; John Gribben; John C. Byrd; Ian W. Flinn; Susan O'Brie 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Safety and Efficacy of PF-3512676 for th

Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study

✍ John A. Thompson; Timothy Kuzel; Beverly J. Drucker; Walter J. Urba; Ronald M. B 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 140 KB

Efficacy of Ketamine in Anesthetic Dosag

Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study

✍ Ralph-Thomas Kiefer; Peter Rohr; Annette Ploppa; Hans-Jürgen Dieterich; John Gro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Open, Randomized, Phase II Study of Sing

Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer

✍ Christian Manegold; Gabriele Koschel; Dagmar Hruska; Kathrin Schott-von-Römer; J 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 155 KB